Article Versions Notes

Boons G, Vandamme T, Ibrahim J, Roeyen G, Driessen A, Peeters D, Lawrence B, Print C, Peeters M, Van Camp G, et al. PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis. Cancers. 2020; 12(6):1461. https://doi.org/10.3390/cancers12061461

Boons, Gitta, Timon Vandamme, Joe Ibrahim, Geert Roeyen, Ann Driessen, Dieter Peeters, Ben Lawrence, Cristin Print, Marc Peeters, Guy Van Camp, and et al. 2020. "PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis" Cancers 12, no. 6: 1461. https://doi.org/10.3390/cancers12061461

Boons, G., Vandamme, T., Ibrahim, J., Roeyen, G., Driessen, A., Peeters, D., Lawrence, B., Print, C., Peeters, M., Van Camp, G., & Op de Beeck, K. (2020). PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis. Cancers, 12(6), 1461. https://doi.org/10.3390/cancers12061461